ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625350 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625350; 2) Community: the network communities that were significantly associated with the response to NSC 625350; 3) Molecule: the relationships between components within communities and NSC 625350; 4) MDR: the compounds that were significantly associated with the NSC 625350.

NSC Compound Enrichment Correlation
NSC 762901 trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide 0.0366216145653013 -0.25354372
NSC 169774 Bromocriptine methanesulfonate 0.038689522570041 -0.37504183
NSC 237020 TA 1067 0.038689522570041 -0.20537639
NSC 254677 Phomazarin 0.038689522570041 0.49627079
NSC 276382 PEPLEOMYCIN 0.038689522570041 0.44318775
NSC 293046 Carbamimidothioic acid, (4-oxo-2-phenyl-4H-1-benzopyran-8-yl)methyl ester, monohydrobromide 0.038689522570041 -0.23559046
NSC 294979 BLEOMYCIN-BAPP 0.038689522570041 0.55923069
NSC 295641 Hydrazinecarbodithioic acid, [1-(2-pyridinyl)ethylidene]-, phenylmethyl ester 0.038689522570041 -0.11290883
NSC 324368 3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-7-methoxy-N,N,N-trimethyl-, hydroxide, inner salt, 4-oxide 0.038689522570041 -0.32022808
NSC 335766 Quinazoline, 4-ethyl-6-methoxy-7-(oxiranylmethoxy)- 0.038689522570041 -0.21427628
Total:60  Current:45    [First] [Prev] [Next] [Last]